Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1995 1
1999 3
2001 1
2002 1
2003 2
2005 2
2007 1
2008 6
2009 5
2010 14
2011 18
2012 16
2013 12
2014 12
2015 12
2016 14
2017 17
2018 15
2019 12
2020 11
2021 16
2022 18
2023 13
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

197 results

Results by year

Filters applied: . Clear all
Page 1
TRPM2.
Faouzi M, Penner R. Faouzi M, et al. Handb Exp Pharmacol. 2014;222:403-26. doi: 10.1007/978-3-642-54215-2_16. Handb Exp Pharmacol. 2014. PMID: 24756715 Review.
Proton beam radiation therapy for vestibular schwannomas-tumor control and hearing preservation rates: a systematic review and meta-analysis.
Santacroce A, Trandafirescu MF, Levivier M, Peters D, Fürweger C, Toma-Dasu I, George M, Daniel RT, Maire R, Nakamura M, Faouzi M, Schiappacasse L, Dasu A, Tuleasca C. Santacroce A, et al. Among authors: faouzi m. Neurosurg Rev. 2023 Jul 4;46(1):163. doi: 10.1007/s10143-023-02060-x. Neurosurg Rev. 2023. PMID: 37402894 Free PMC article. Review.
Pharmacology of JNJ-28583113: A novel TRPM2 antagonist.
Fourgeaud L, Dvorak C, Faouzi M, Starkus J, Sahdeo S, Wang Q, Lord B, Coate H, Taylor N, He Y, Qin N, Wickenden A, Carruthers N, Lovenberg TW, Penner R, Bhattacharya A. Fourgeaud L, et al. Among authors: faouzi m. Eur J Pharmacol. 2019 Jun 15;853:299-307. doi: 10.1016/j.ejphar.2019.03.043. Epub 2019 Apr 6. Eur J Pharmacol. 2019. PMID: 30965058
Safety and immunogenicity of a synthetic nanoparticle-based, T cell priming peptide vaccine against dengue in healthy adults in Switzerland: a double-blind, randomized, vehicle-controlled, phase 1 study.
Miauton A, Audran R, Besson J, Maby-El Hajjami H, Karlen M, Warpelin-Decrausaz L, Sene L, Schaufelberger S, Faivre V, Faouzi M, Hartley MA, Spertini F, Genton B. Miauton A, et al. Among authors: faouzi m. EBioMedicine. 2024 Jan;99:104922. doi: 10.1016/j.ebiom.2023.104922. Epub 2023 Dec 20. EBioMedicine. 2024. PMID: 38128414 Free PMC article. Clinical Trial.
197 results